NCT06252662View on ClinicalTrials.gov

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

PHASE4RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions

Breast Cancer

Interventions

DRUG

Dexmedetomidine

block duration extension additive

DRUG

Liposomal bupivacaine

Control arm, comparison for block duration with dexmedetomidine

Trial Locations (1)

23708

RECRUITING

Naval Medical Center Portsmouth, Portsmouth

All Listed Sponsors

lead

United States Naval Medical Center, Portsmouth

FED

NCT06252662 - Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies | Biotech Hunter | Biotech Hunter